Evidence map›Paper›PMID 41285750›Full record

ArticleBlood cancer journal2025

Epidemiology and survival of patients with T-cell prolymphocytic leukemia.

Nadine Wolgast, Eric Amelunxen, Lars Fransecky, Philipp Altrock, Thomas Beder, Julian Ronnacker, Frederik Peters, Soo-Zin Kim-Wanner, Monika Brüggemann, Christiane Pott and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nadine Wolgast *Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
Eric Amelunxen *Department of Medicine IV, Nephrology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
Lars FranseckyDepartment of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
Philipp AltrockDepartment of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
Thomas BederDepartment of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.ORCID http://orcid.org/0009-0000-2278-5054
Julian RonnackerDepartment of Medicine A, University Hospital Münster, Münster, Germany.ORCID http://orcid.org/0009-0006-1955-0709
Frederik PetersHamburg Cancer Registry, Hamburg, Germany.ORCID http://orcid.org/0000-0001-5832-8410
Soo-Zin Kim-WannerHessian Cancer Registry, Hessian Office for Health and Care, Frankfurt, Germany.
Monika BrüggemannDepartment of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
Christiane PottDepartment of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
Alexander KatalinicUniversity Cancer Centre Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel, Germany.ORCID http://orcid.org/0000-0003-0490-1554
Claudia D Baldus *Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.ORCID http://orcid.org/0000-0002-0748-834X
David Baden *Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany. david.baden@uksh.de.ORCID http://orcid.org/0000-0002-4519-1002

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 413490537
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41285750
PMCPMC12644601

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.